Osaka, Japan

Hideaki Hara

This inventor holds 1 USPTO granted patent. Top assignee: Kanebo, Limited. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideaki Hara. Retrieved from https://idiyas.com/inventor/hideaki-hara-gsbm8xp8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hideaki Hara

Introduction

Hideaki Hara is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his work on quinazoline derivatives. His innovative approach has led to advancements in remedies for cerebral dysfunction.

Latest Patents

Hara holds a patent for a quinazoline derivative, which is represented by a specific formula. This compound is recognized for its potential as a cerebral dysfunction remedying agent. The patent details processes for the production of this derivative and its pharmacologically acceptable acid addition salts.

Career Highlights

Hara is associated with Kanebo, Limited, a company known for its commitment to research and development in the pharmaceutical sector. His work has been instrumental in advancing therapeutic options for patients suffering from cerebral dysfunction.

Collaborations

Hara has collaborated with esteemed colleagues such as Ryuichi Iemura and Manabu Hori. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Hideaki Hara's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to impact the development of effective treatments for cerebral dysfunction.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…